APA

ten Bosch G. J., Kessler J. H., Joosten A. M., Bres-Vloemans A. A., Geluk A., Godthelp B. C., van Bergen J., Melief C. J. & Leeksma O. C. (19990817). A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct. : Blood.

Chicago

ten Bosch G J, Kessler J H, Joosten A M, Bres-Vloemans A A, Geluk A, Godthelp B C, van Bergen J, Melief C J and Leeksma O C. 19990817. A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct. : Blood.

Harvard

ten Bosch G. J., Kessler J. H., Joosten A. M., Bres-Vloemans A. A., Geluk A., Godthelp B. C., van Bergen J., Melief C. J. and Leeksma O. C. (19990817). A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct. : Blood.

MLA

ten Bosch G J, Kessler J H, Joosten A M, Bres-Vloemans A A, Geluk A, Godthelp B C, van Bergen J, Melief C J and Leeksma O C. A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct. : Blood. 19990817.